Dados B3 › CAMB3
CAMB3 (Cambuci): has profit grown?
CAMB3 (Cambuci): in 2024, net income attributable to controlling shareholders was R$ 76.4 million, up 6% versus 2023 (a profit of R$ 71.9 million); five years earlier (2019), a profit of R$ 20.2 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2024 | R$ 76.4 million | up 6% |
| 2023 | R$ 71.9 million | up 27% |
| 2022 | R$ 56.6 million | up 106% |
| 2021 | R$ 27.5 million | up 25% |
| 2020 | R$ 22.0 million | up 9% |
| 2019 | R$ 20.2 million | up 21% |
| 2018 | R$ 16.6 million | down 63% |
| 2017 | R$ 44.7 million | a turn from loss to profit |
| 2016 | -R$ 33.4 million | a loss in both years |
| 2015 | -R$ 28.1 million | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/CAMB3/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: CAMB3.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:10 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:10 UTC. If this does not match /saude, you are reading a cached copy.